These are the stocks posting the largest moves before the bell.Market Insiderread more
Removing Neumann is a difficult decision for Son, who has long believed in WeWork and Neumann's vision to quickly expand the company.Technologyread more
The next three weeks are among the rockiest, on a historical basis, of the entire calendar.Trading Nationread more
Of all the cases of economic espionage charged by the DOJ's National Security Division since 2012, more than 80% of them implicated China.World Politicsread more
Worries over global economic growth were set to thwart Wall Street's run to record highs on Monday.Marketsread more
In his new memoir, "The Ride of a Lifetime," Iger explains why he decided against the deal to buy Twitter.Technologyread more
Ad-tech company The Trade Desk is launching a campaign to show how it differs from tech giants like Google and Facebook.Technologyread more
The streaming wars may have claimed a new victim, and one technical analyst says it could be about to get worse.Trading Nationread more
"Whilst there is a big dispute at the moment, I think there's also potential for resolution," UBS chairman Axel Weber says of the U.S.-China trade negotiations.Singapore Summitread more
No quid pro quo, there was nothing," Trump said the call. "It was a perfect conversation."Politicsread more
On Sunday, the 71st Primetime Emmy Awards honored the best comedies, dramas, limited and variety series from the last year.Entertainmentread more
Hims, an e-commerce company that sells men's health and beauty products, including treatments for erectile dysfunction and hair loss, is looking to expand into a new vertical: Women.
The company has pitched potential investors on a women's brand dubbed "Hers," which would provide similar products to ladies, including things like treatments for hair loss, skin-boosting treatments and apparel, according to two people familiar with the company's pitch. That could put Hims in a position to compete with other venture-backed women's consumer brands for a health-focused generation, like Glossier, which sells beauty products, and Ritual, maker of a multivitamin for women.
To fuel the expansion, Hims has had recent talks with potential investors about raising more than $100 million at an $800 million valuation, say three sources familiar. It has also been fielding inbound interest.
Several cautioned that no deal is imminent, however, and the company may decide to wait before trying to raise more money from investors after just closing a $50 million round in June. According to a person pitched on that round, the company claimed to have an annualized revenue run rate between $20 million and $40 million at that time, a mere eight months after its November launch.
Hims competes with another men's brand, Roman, which is also experiencing rapid growth, according to sources.
These companies are taking advantage of recent regulatory changes around telemedicine, which opens up more opportunities for doctors to prescribe medicines online. Andrew Dudum, Hims' CEO, has said that he plans to create a $10 billion health and wellness brand. The company also said it pulled in $1 million in revenues in its first week after launch.
The company, which has raised $97 million in total, has spent some of its money on cheeky ads featuring sad slumped-over cacti and spiky green plants, geared towards young hipsters who are embarrassed to talk about erectile dysfunction at the doctor's office or ask about beauty products at a retail store. It has also expanded into other areas, like vitamins, merchandise and cold sore kits.
Hims declined to comment on its product or fundraising plans.